期刊文献+

UPLC测定注射用醋酸西曲瑞克中有关物质的含量 被引量:1

Determination of Related Substances of Cetrorelix Acetate Injection by UPLC
原文传递
导出
摘要 目的建立UPLC测定注射用醋酸西曲瑞克的有关物质含量的方法。方法采用色谱柱ACQUITY UPLC CSHTM C;(2.1 mm×150 mm,1.7μm),流动相A为0.05 mol·L^(-1)高氯酸钠溶液(磷酸调节pH值至2.0),流动相B为0.05 mol·L^(-1)高氯酸钠溶液-乙腈(30∶70)(磷酸调节pH值至2.0),梯度洗脱,流速为0.2 mL·min^(-1),检测波长为226 nm,进样量为1μL。结果杂质A、B、C、D、E、F的检测浓度范围分别为0.1278~6.3904,0.1244~6.2213,0.1268~6.3408,0.1205~6.0256,0.1209~6.0473,0.1277~6.3894μg·mL^(-1),各杂质检出限约为0.04 ng,杂质B、D、E定量限约为0.12 ng,杂质A、C、F定量限约为0.13 ng,平均加样回收率分别为97.4%,95.2%,101.5%,105.3%,100.7%,97.4%,RSD分别为1.7%,3.0%,3.8%,2.4%,0.8%,2.8%(n=9)。结论本方法快速、简便、准确、专属性强,可用于注射用醋酸西曲瑞克中有关物质的定量研究。 OBJECTIVE To establish an UPLC method for determination of related substances of Cetrorelix Acetate injection.METHODS The separation was performed on ACQUITY UPLC CSHTMC;column(2.1 mm×150 mm,1.7μm),0.05 mol·L^(-1)sodium perchlorate solution(adjust the pH with phosphoric acid to 2.0)was used as mobile phase A,and 0.05 mol·L^(-1)sodium perchlorate solution-acetonitrile(30︰70)(adjust the pH with phosphoric acid to 2.0)was used as mobile phase B,with a gradient elution.Flow rate was 0.2 mL·min^(-1),the detection wavelength was 226 nm and sample volume was 1μL.RESULTS The linear ranges of impurity A,B,C,D,E and F were 0.1278-6.3904,0.1244-6.2213,0.1268-6.3408,0.1205-6.0256,0.1209-6.0473,0.1277-6.3894μg·mL^(-1),respectively.The limits of detection of each impurities was about 0.04 ng.The limits of quantitation of impurity B,D,E were about 0.12 ng,that of impurity A,C,F were about 0.13 ng.The average recoveries were 97.4%,95.2%,101.5%,105.3%,100.7%,97.4%,respectively.RSDs were 1.7%,3.0%,3.8%,2.4%,0.8%,2.8%(n=9),respectively.CONCLUSION The method is rapid,simple,accurate and specific and can be used for the quantitative study on related substances in Cetrorelix Acetate for injection.
作者 薛巧如 刘冰滢 陈华 邓锋 XUE Qiaoru;LIU Bingying;CHEN Hua;DENG Feng(Guangdong Institute for Drug Control,NMPA Key Laboratory of Quality Control of Blood Products,Guangdong Drug Administration Key Laboratory of Quality Control and Research of Blood Products,Guangzhou 510663,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2022年第2期203-207,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 超高效液相色谱法 醋酸西曲瑞克 有关物质 UPLC cetrorelix acetate related substances
作者简介 薛巧如,女,硕士,副主任药师,E-mail:12236008@qq.com;通讯作者:陈华,女,硕士,主任药师,E-mail:gdchenhua@sina.com
  • 相关文献

参考文献6

二级参考文献61

  • 1杨学森,汪华侨,袁群芳,谢瑶,姚志彬,叶小舟,吴继明,邹爱国.Fmoc固相直接法合成Aβ_(1-15)肽疫苗及其免疫活性[J].中山大学学报(医学科学版),2006,27(2):121-125. 被引量:4
  • 2张德波,冯诚,罗洁,杨幼琪.乳状液型注射液溶血与凝聚试验探讨[J].中国药品标准,2006,7(5):51-53. 被引量:3
  • 3张海英,孙燕萍,柳青.控制性超排卵中血清E_2、LH水平对体外受精—胚胎移植的影响[J].广西医科大学学报,2006,23(6):898-900. 被引量:5
  • 4白振锋,刘全忠,田敏卿,马亚平.甲状旁腺素1-34肽的固相合成[J].合成化学,2007,15(3):388-390. 被引量:2
  • 5BAJUSZ S, KOVACS M, GAZDAG M, et al. Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects [ J ]. Proc Natl Acad Sci USA, 1988,85 (5) : 1637 - 1641.
  • 6EMONS G,GRUNDKER C,GUNTHERT A R,et al. GnRH antagonists in the treatment of gynecological and breast cancers [ J]. Endocr Relat Cancer,2003,10 (2) :291 -299.
  • 7REISSMANN T,SCHALLY A V,BOUCHARD P,et al. The LH-RH antagonist cetrorelix: a review [J].Hum Reprod Update,2000,6(4) :322 -331.
  • 8SCHALLY A V, BAJUSZ S. LH-RH antagonists: US ,4800191 [ P]. 1989 - 06 - 24.
  • 9YU H M,CHEN S T, WANG K T. Enhanced coupling efficiency in solid-phase peptide synthesis by microwave irradiation [ J ]. J Org Chem, 1992, 57 (18) :4781 -4784.
  • 10ZURIT A T, OSHRAT C E, KARMIEL S S, et al. Methods for the production of peptides derivatives: US ,2006/0276626A1 [ P]. 2006 - 12 - 07.

共引文献46

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部